The chemical class of Speedy A activators listed here primarily includes inhibitors of cyclin-dependent kinases (CDKs), which play a crucial role in cell cycle regulation. These activators are not specific to Speedy A but could potentially influence its function indirectly through their impact on CDK activity and cell cycle progression. Compounds like Palbociclib, Ribociclib, and Abemaciclib specifically inhibit CDK4/6, key regulators of the G1/S transition in the cell cycle, a process in which Speedy A is also involved. By modulating CDK4/6 activity, these inhibitors might indirectly affect Speedy A function.
Broad-spectrum CDK inhibitors, such as Flavopiridol, Roscovitine, Olomoucine, Purvalanol A, Dinaciclib, Seliciclib, Milciclib, and SNS-032, target multiple CDKs. These inhibitors could impact Speedy A indirectly by altering the overall regulation of the cell cycle and CDK activity. It is important to note that the relationship between these CDK inhibitors and Speedy A is theoretical, based on the known roles of CDKs in cell cycle regulation and the involvement of Speedy A in these processes. Direct studies focusing on Speedy A and these chemicals might be limited. Therefore, experimental validation is essential for confirming any potential interactions or effects on Speedy A.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
A CDK4/6 inhibitor, could indirectly influence Speedy A by altering CDK activity and cell cycle progression. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
A CDK inhibitor, might impact Speedy A function indirectly through broad inhibition of CDKs. | ||||||
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
A selective inhibitor of certain CDKs, might influence Speedy A function through its effects on CDK activity. | ||||||
Purvalanol A | 212844-53-6 | sc-224244 sc-224244A | 1 mg 5 mg | $71.00 $291.00 | 4 | |
A potent CDK inhibitor, could indirectly affect Speedy A activity by influencing CDK-dependent cell cycle regulation. | ||||||
PD 0332991 Isethionate | 827022-33-3 | sc-478943 | 1 mg | $300.00 | ||
Also known as Palbociclib; could modulate Speedy A function indirectly through CDK4/6 inhibition. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $242.00 $871.00 | 1 | |
A broad-spectrum CDK inhibitor, potentially affecting Speedy A through its effects on CDK activity and cell cycle progression. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
A CDK4/6 inhibitor, could influence Speedy A activity indirectly by modulating CDK-dependent cell cycle processes. | ||||||
Abemaciclib | 1231929-97-7 | sc-507342 | 10 mg | $110.00 | ||
Another CDK4/6 inhibitor, might impact Speedy A function indirectly through effects on CDK activity and cell cycle regulation. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
A CDK inhibitor, could affect Speedy A activity indirectly by targeting multiple CDKs involved in cell cycle control. | ||||||
SNS-032 | 345627-80-7 | sc-364621 sc-364621A | 5 mg 10 mg | $169.00 $262.00 | ||
A potent CDK inhibitor, could indirectly modulate Speedy A function by affecting CDK regulation and cell cycle progression. |